ID   NIPBC-1
AC   CVCL_U921
SY   National Institute of Pathology Breast Cancer-1
DR   Wikidata; Q54930612
RX   PubMed=24502646;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Indian.
CC   Doubling time: 33.25 hours (PubMed=24502646).
CC   Karyotypic information: Near tetraploid karyotype with a modal number of 58 to 62 chromosomes.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=24502646).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=24502646
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TPOX: 8,13
ST   vWA: 12
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=24502646; DOI=10.1186/1475-2867-14-14;
RA   Pandrangi S.L., Raju Bagadi S.A., Sinha N.K., Kumar M., Dada R.,
RA   Lakhanpal M., Soni A., Malvia S., Simon S., Chintamani C., Mohil R.S.,
RA   Bhatnagar D., Saxena S.;
RT   "Establishment and characterization of two primary breast cancer cell
RT   lines from young Indian breast cancer patients: mutation analysis.";
RL   Cancer Cell Int. 14:14.1-14.20(2014).
//